Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study
Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study
复制标题
DOI：
10.1093/intqhc/mzaa144
复制
发表时间：
2021-01-01
影响因子：
2.6
通讯作者：
Unal, Serhat
中科院分区：
文献类型：
--
作者：
Uyaroglu, Oguz Abdullah;Basaran, Nursel Calik;Unal, Serhat
背景：30天再入院率是衡量患者安全和医院质量绩效的重要指标。本研究旨在了解某三级大学医院2019年轻、中度冠状病毒病（COVID-19）患者出院后30天的再入院率，并探讨可能的再入院因素。方法：这是一项观察性单中心研究。从前瞻性记录患者信息的研究数据库中检索诊断为COVID-19的住院患者的流行病学和临床资料。从医院信息管理系统和国家卫生信息系统中获取再入院数据，以检测患者出院后30天内是否再次入院。纳入2020年3月20日（第一例病例入院时）至2020年4月26日期间在COVID-19病房诊断为轻度或中度COVID-19的成年患者（>= 18岁）。结果：3月26日至5月1日，新冠肺炎病区出院轻、中度（非危重）患者154例，其中再入院11例（7.1%）。中位再入院时间为8.1天（四分位数差[IQR]=5.2）。2例（18.1%）为轻度疾病，其余9例（81.9%）为中度疾病。两名65岁以上的转移性癌症和高血压患者在再入院期间发生败血症并在医院死亡。恶性肿瘤（18.7% vs. 2.1%， P=0.04）和高血压（45.5% vs. 14%， P=0.02）在再入院患者中更为常见。结论：这是文献中首次报道COVID-19 30天再入院率的研究之一。需要更全面的研究来揭示COVID-19再入院的原因和预测因素。
Background: The 30-day readmission rate is an important indicator of patient safety and hospital's quality performance. In this study, we aimed to find out the 30-day readmission rate of mild and moderate severity coronavirus disease of 2019 (COVID-19) patients discharged from a tertiary care university hospital and to demonstrate the possible factors associated with readmission.Methods: This is an observational, single-center study. Epidemiological and clinical data of patients who were hospitalized with a diagnosis of COVID-19 were retrieved from a research database where patient information was recorded prospectively. Readmission data were sought from the hospital information management system and the National Health Information System to detect if the patients were readmitted to any hospital within 30 days of discharge. Adult patients (>= 18 years old) hospitalized in COVID-19 wards with a diagnosis of mild or moderate COVID-19 between 20 March 2020 (when the first case was admitted to our hospital) and 26 April 2020 were included.Results: From 26 March to 1 May, there were 154 mild or moderate severity (non-critical) COVID-19 patients discharged from COVID-19 wards, of which 11 (7.1%) were readmitted. The median time of readmission was 8.1 days (interquartile range [IQR]=5.2). Two patients (18.1%) were categorized to have mild disease and the remaining 9 (81.9%) as moderate disease. Two patients who were over 65 years of age and had metastatic cancers and hypertension developed sepsis and died in the hospital during the readmission episode. Malignancy (18.7% vs. 2.1%, P=0.04) and hypertension (45.5% vs. 14%, P=0.02) were more common in those who were readmitted.Conclusions: This is one of the first studies to report on 30-day readmission rate of COVID-19 in the literature. More comprehensive studies are needed to reveal the causes and predictors of COVID-19 readmissions.